Is the coprescription of beta blockers and beta2 agonists justified in COPD?
作者信息
Singh A
出版信息
Thorax. 2008 Nov;63(11):1026; author reply 1026.
PMID:18984821
Abstract
摘要
相似文献
1
Is the coprescription of beta blockers and beta2 agonists justified in COPD?
Thorax. 2008 Nov;63(11):1026; author reply 1026.
2
Use of beta-blockers in patients with COPD.
Ann Pharmacother. 2004 Jan;38(1):142-5. doi: 10.1345/aph.1D113.
3
[Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Pol Merkur Lekarski. 2008 Feb;24(140):121-4.
4
Use of beta blockers in patients with COPD.
Thorax. 2008 Apr;63(4):296-8. doi: 10.1136/thx.2007.091280.
5
Biases in the observational study of beta blockers in COPD.
Thorax. 2008 Nov;63(11):1026-7; author reply 1027.
6
Pulmonary effects of nebivolol.
Ther Adv Cardiovasc Dis. 2009 Aug;3(4):329-34. doi: 10.1177/1753944709339968.
7
A curious case of beta-blockers in chronic obstructive pulmonary disease.
Arch Intern Med. 2010 May 24;170(10):849-50. doi: 10.1001/archinternmed.2010.97.
8
Treatment with beta blockers in people with COPD.
BMJ. 2011 May 10;342:d2655. doi: 10.1136/bmj.d2655.
9
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.
10
Beta-blocker use in patients with COPD.
Am Fam Physician. 2006 Dec 1;74(11):1858.
Zotero 插件